Laura Versmee received her MD degree from the University of Limoges, France in 2011, and then she specialized in hematology. Her thesis was a clinical research on epidemiology, management and outcome of cancer patients in an ED setting. As a clinician, she devoted time to patients with lymphoma and multiple myeloma. Versmee’s research has been focused on primary central nervous system lymphoma. She joined the Avillach lab in 2017. She is currently working on a NHIBL project : Patient-centric information commons under FAIR principals (PIC-FAIR) for TOPMed (Transomics for Precision Medicine).
No publications were found.